100
Participants
Start Date
July 31, 2024
Primary Completion Date
September 30, 2025
Study Completion Date
September 30, 2025
Chlamydia trachomatis and Neisseria gonorrhea self-swab(s) and/or urine collection. Clinical assessment and prescribing of treatment for participants with positive test results
Participants will be tested by self-swab sample (pharyngeal, vaginal or rectal) and/or urine sample (urogenital) for Chlamydia trachomatis and Neisseria gonorrhea. Selection of swab(s) or urine-based testing will be determined by the individual's sexual risk factors. Participants who have positive CT and/or NG test results will undergo clinical assessment of the CT and/or NG infection by the pharmacist and a prescription will be issued for treatment as appropriate.
Brookline Pharmacy, Bedford
Moffatt's Pharmacy, Dartmouth
Boyd's Pharmasave, Halifax
SRx Pharmacy, Halifax
Queen Elizabeth II Health Sciences Centre, Halifax
Nova Scotia Health Authority
OTHER
Dalhousie University
OTHER